132 related articles for article (PubMed ID: 2070052)
1. Expression of the c-myc proto-oncogene in multiple myeloma and chronic lymphocytic leukemia: an in situ analysis.
Greil R; Fasching B; Loidl P; Huber H
Blood; 1991 Jul; 78(1):180-91. PubMed ID: 2070052
[TBL] [Abstract][Full Text] [Related]
2. Expression of the c-myc protein is down-regulated at the terminal stages during in vitro differentiation of B-type chronic lymphocytic leukemia cells.
Larsson LG; Schena M; Carlsson M; Sällström J; Nilsson K
Blood; 1991 Mar; 77(5):1025-32. PubMed ID: 1899807
[TBL] [Abstract][Full Text] [Related]
3. Increased expression of the c-myc gene may be related to the aggressive transformation of human myeloma cells.
Nobuyoshi M; Kawano M; Tanaka H; Ishikawa H; Tanabe O; Iwato K; Asaoku H; Sakai A; Kuramoto A
Br J Haematol; 1991 Apr; 77(4):523-8. PubMed ID: 2025578
[TBL] [Abstract][Full Text] [Related]
4. Rapid expression of protooncogenes c-fos and c-myc in B-chronic lymphocytic leukemia cells during differentiation induced by phorbol ester and calcium ionophore.
Drexler HG; Janssen JW; Brenner MK; Hoffbrand AV; Bartram CR
Blood; 1989 May; 73(6):1656-63. PubMed ID: 2496772
[TBL] [Abstract][Full Text] [Related]
5. Biclonal origin prevails in concomitant chronic lymphocytic leukemia and multiple myeloma.
Pantic M; Schroettner P; Pfeifer D; Rawluk J; Denz U; Schmitt-Gräff A; Veelken H; Wäsch R; Engelhardt M
Leukemia; 2010 Apr; 24(4):885-90. PubMed ID: 20090779
[No Abstract] [Full Text] [Related]
6. The oncoprotein phenotype of plasma cells from patients with multiple myeloma.
Brown RD; Pope B; Luo XF; Gibson J; Joshua D
Leuk Lymphoma; 1994 Dec; 16(1-2):147-56. PubMed ID: 7696921
[TBL] [Abstract][Full Text] [Related]
7. Separate clones in concomitant multiple myeloma and a second B-cell neoplasm demonstrated by molecular and immunophenotypic analysis.
Novak PM; Mattson JC; Crisan D; Chen J; Poulik MD; Decker D
Eur J Haematol; 1995 Apr; 54(4):254-61. PubMed ID: 7789471
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of trisomy 12 by fluorescence in situ hybridization in peripheral blood, bone marrow and lymph nodes of patients with B-cell chronic lymphocytic leukemia.
Liso V; Capalbo S; Lapietra A; Pavone V; Guarini A; Specchia G
Haematologica; 1999 Mar; 84(3):212-7. PubMed ID: 10189384
[TBL] [Abstract][Full Text] [Related]
9. Proto-oncogene expression in bovine peripheral blood leukemic lymphocytes during their spontaneous proliferation, differentiation and apoptosis in vitro.
Kalvelyte AV; Pabrezaite LC
Leuk Res; 1998 Feb; 22(2):135-43. PubMed ID: 9593470
[TBL] [Abstract][Full Text] [Related]
10. Expression of A-myb, but not c-myb and B-myb, is restricted to Burkitt's lymphoma, sIg+ B-acute lymphoblastic leukemia, and a subset of chronic lymphocytic leukemias.
Golay J; Luppi M; Songia S; Palvarini C; Lombardi L; Aiello A; Delia D; Lam K; Crawford DH; Biondi A; Barbui T; Rambaldi A; Introna M
Blood; 1996 Mar; 87(5):1900-11. PubMed ID: 8634438
[TBL] [Abstract][Full Text] [Related]
11. Expression of C-myc p62 oncoprotein in multiple myeloma: an immunohistochemical study of 180 cases.
Skopelitou A; Hadjiyannakis M; Tsenga A; Theocharis S; Alexopoulou V; Kittas C; Agnantis N
Anticancer Res; 1993; 13(4):1091-5. PubMed ID: 8352531
[TBL] [Abstract][Full Text] [Related]
12. Application of fine-needle aspiration to the demonstration of ERBB2 and MYC expression by in situ hybridization in breast carcinoma.
Soini Y; Mannermaa A; Winqvist R; Kamel D; Poikonen K; Kiviniemi H; Pääkkö P
J Histochem Cytochem; 1994 Jun; 42(6):795-803. PubMed ID: 7910618
[TBL] [Abstract][Full Text] [Related]
13. The combination of C-Myc rearrangement and 1q21 gain is associated with poor prognosis in multiple myeloma.
Jin Y; Yu X; Du J; Li H; Tang W; Jia C; Zan Y; Chen M; Zhang Y; Yu M; Rong W; Zhou D; Zhuang J
Ann Hematol; 2021 May; 100(5):1251-1260. PubMed ID: 33686491
[TBL] [Abstract][Full Text] [Related]
14. In situ hybridization for the detection of low copy numbers of c-abl oncogene mRNA in lymphoma cells: technical approach and comparison with results with anti-oncoprotein antibodies.
Greil R; Fasching B; Huber H
Lab Invest; 1989 Apr; 60(4):574-82. PubMed ID: 2651801
[TBL] [Abstract][Full Text] [Related]
15. Disease progression in patients with multiple myeloma is associated with a concurrent alteration in the expression of both oncogenes and tumour suppressor genes and can be monitored by the oncoprotein phenotype.
Pope B; Brown R; Luo XF; Gibson J; Joshua D
Leuk Lymphoma; 1997 May; 25(5-6):545-54. PubMed ID: 9250826
[TBL] [Abstract][Full Text] [Related]
16. MYC amplification on double minute chromosomes in plasma cell leukemia with double IGH/CCND1 fusion genes.
Yamamoto K; Yakushijin K; Ito M; Goto H; Higashime A; Kajimoto K; Hayashi Y; Matsuoka H; Minami H
Cancer Genet; 2020 Apr; 242():35-40. PubMed ID: 32035866
[TBL] [Abstract][Full Text] [Related]
17. Proliferation centres of chronic lymphocytic leukaemia/small lymphocytic lymphoma have enhanced expression of MYC protein, which does not result from rearrangement or gain of the MYC gene.
Gibson SE; Leeman-Neill RJ; Jain S; Piao W; Cieply KM; Swerdlow SH
Br J Haematol; 2016 Oct; 175(1):173-5. PubMed ID: 26568397
[No Abstract] [Full Text] [Related]
18. Richter transformation with c-MYC overexpression: report of three cases.
Wang L; Aghel A; Peterson B; Wang-Rodriguez J; Wang HY; Zhao XF
Int J Clin Exp Pathol; 2015; 8(6):7540-6. PubMed ID: 26261666
[TBL] [Abstract][Full Text] [Related]
19. Expression of multiple beta 1 integrins on circulating monoclonal B cells in patients with multiple myeloma.
Jensen GS; Belch AR; Mant MJ; Ruether BA; Yacyshyn BR; Pilarski LM
Am J Hematol; 1993 May; 43(1):29-36. PubMed ID: 7686332
[TBL] [Abstract][Full Text] [Related]
20. The distinct gene expression profiles of chronic lymphocytic leukemia and multiple myeloma suggest different anti-apoptotic mechanisms but predict only some differences in phenotype.
Zent CS; Zhan F; Schichman SA; Bumm KH; Lin P; Chen JB; Shaughnessy JD
Leuk Res; 2003 Sep; 27(9):765-74. PubMed ID: 12804633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
